As per the recently published report by MarketsandMarket™, The report "Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Global Forecast to 2028", is projected to reach USD 4.3 billion by 2028 from USD 2.1 billion in 2023, at a CAGR of 15.5% from 2023 to 2028.
Download
PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111696976
Browse
- 94 Market Data Tables
- 40
Figures
- 196 Pages and in-depth TOC on " Theranostics
Market - Global Forecast to 2028”
Some of the prominent key players are:
- Advanced
Accelerator Applications (France),
- Bayer
AG (Germany),
- GE
Healthcare (US) and many more......
Mergers & acquisitions, investments & expansions,
partnerships & collaborations, and new product developments are some of the
major strategies adopted by these key players to enhance their positions in the
Theranostics Market.
- Based on the product, the global theranostics market is
segmented into diagnostic imaging, radiopharmaceuticals, IVD/Biomarker
screening, and software and services. The radiopharmaceuticals segment is
anticipated to register the highest growth rate over the forecast period
and also accounted for the highest share of the theranostics market in
2022.
- Based on application, the theranostics market is segmented
into prostate cancer, bone metastasis, other cancer, and other
applications. The prostate cancer segment accounted for the largest share
of the market in 2022 and is also expected to grow at the highest CAGR
during the forecast period.
- Based on end user, the global theranositcs market is
segmented into hospitals and cancer centers, theranostics centers, and
research and academic centers. The hospitals and cancer care centers
segment accounted for the largest share of the market in 2022. Consistent
rise in the number of hospitals and rising old-age population are driving
the growth of this segment.
- The Asia Pacific theranostics market is anticipated to
register the highest growth from 2023 to 2028. The key players of
theranostics market are focusing on expanding their footprint in the APAC
region. This region is witnessing a significant rise in the adoption of
the treatment by different end user facilities in the region.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=111696976
The new research study consists of industry
trends, pricing analysis, patent analysis, conference and webinar materials,
key stakeholders, and buying behaviour in the market. Increasing establishment
of hospitals, rising focus on targeted therapies, and introduction of novel
theranostic approaches are expected to drive the market during the forecast
period. Introduction of artificial intelligence (AI) helps to improve the
diagnostic accuracy. Recent FDA approvals increases the awareness and supports
rising adoption of theranostics.
No comments:
Post a Comment